首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >PNAS Plus: Increased gene copy number of DEFA1/DEFA3 worsens sepsis by inducing endothelial pyroptosis
【2h】

PNAS Plus: Increased gene copy number of DEFA1/DEFA3 worsens sepsis by inducing endothelial pyroptosis

机译:PNAS Plus:DEFA1 / DEFA3的基因拷贝数增加通过诱导内皮细胞凋亡而使败血症恶化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sepsis claims an estimated 30 million episodes and 6 million deaths per year, and treatment options are rather limited. Human neutrophil peptides 1–3 (HNP1–3) are the most abundant neutrophil granule proteins but their neutrophil content varies because of unusually extensive gene copy number polymorphism. A genetic association study found that increased copy number of the HNP-encoding gene DEFA1/DEFA3 is a risk factor for organ dysfunction during sepsis development. However, direct experimental evidence demonstrating that these risk alleles are pathogenic for sepsis is lacking because the genes are present only in some primates and humans. Here, we generate DEFA1/DEFA3 transgenic mice with neutrophil-specific expression of the peptides. We show that mice with high copy number of DEFA1/DEFA3 genes have more severe sepsis-related vital organ damage and mortality than mice with low copy number of DEFA1/DEFA3 or wild-type mice, resulting from more severe endothelial barrier dysfunction and endothelial cell pyroptosis after sepsis challenge. Mechanistically, HNP-1 induces endothelial cell pyroptosis via P2X7 receptor-mediating canonical caspase-1 activation in a NLRP3 inflammasome-dependent manner. Based on these findings, we engineered a monoclonal antibody against HNP-1 to block the interaction with P2X7 and found that the blocking antibody protected mice carrying high copy number of DEFA1/DEFA3 from lethal sepsis. We thus demonstrate that DEFA1/DEFA3 copy number variation strongly modulates sepsis development in vivo and explore a paradigm for the precision treatment of sepsis tailored by individual genetic information.
机译:脓毒症每年估计导致3000万发作,600万人死亡,治疗选择非常有限。人类嗜中性粒细胞肽1-3(HNP1-3)是最丰富的嗜中性粒细胞颗粒蛋白,但由于异常广泛的基因拷贝数多态性,它们的嗜中性粒细胞含量有所不同。一项遗传协会研究发现,HNP编码基因DEFA1 / DEFA3的拷贝数增加是脓毒症发生期间器官功能障碍的危险因素。但是,由于这些基因仅存在于某些灵长类动物和人类中,因此缺乏直接的实验证据证明这些风险等位基因是败血症的致病性。在这里,我们生成具有中性粒细胞特异性表达的DEFA1 / DEFA3转基因小鼠。我们显示,具有较高拷贝数的DEFA1 / DEFA3基因的小鼠比具有较低拷贝数的DEFA1 / DEFA3的小鼠或野生型小鼠具有更严重的败血症相关的重要器官损伤和死亡率,这是由于更严重的内皮屏障功能障碍和内皮细胞引起的脓毒症激发后发生光解。从机制上讲,HNP-1通过P2X7受体介导的典型caspase-1活化以NLRP3炎症小体依赖性方式诱导内皮细胞热凋亡。基于这些发现,我们设计了一种针对HNP-1的单克隆抗体,以阻断与P2X7的相互作用,并发现该阻断抗体可保护携带高拷贝数DEFA1 / DEFA3的小鼠免遭致命性败血症的侵害。因此,我们证明DEFA1 / DEFA3拷贝数变化强烈地调节了败血症在体内的发展,并探索了由个体遗传信息量身定制的精确治疗败血症的范例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号